{
     "PMID": "1682438",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19911213",
     "LR": "20161123",
     "IS": "0386-846X (Print) 0386-846X (Linking)",
     "VI": "14",
     "IP": "4",
     "DP": "1991 Apr",
     "TI": "MCI-9042: high affinity for serotonergic receptors as assessed by radioligand binding assay.",
     "PG": "177-81",
     "AB": "This study assessed the specificity of displacement potencies of MCI-9042 [+/-)-1-[o-[2-(m-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)- 2-propyl hydrogen succinate hydrochloride), a new antiplatelet agent, in [3H]4-bromo-2,5-dimethoxyphenylisopropylamine [( 3H]DOB) and [3H]ketanserin binding to 5HT2-serotonergic receptors in the rat brain using the radioligand binding method. The assessment of the displacement potencies of MCI-9042 and its derivative, M-1 [(+/-)-1-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)- 2-propanol)hydrochloride), on alpha 1-, alpha 2-, beta-adrenergic, 5HT1-, 5HT2- and muscarinic receptors were also studied. MCI-9042 and M-1 showed strong displacement effects to 5HT2-receptors using [3H]DOB binding and [3H]ketanserin binding sites, and weak displacement effects for [3H]serotonin, [3H]prazosin, [3H]p-aminoclonidine, [3H]CGP12177 and [3H]QNB binding to 5HT1-, alpha 1-, alpha 2-, beta-adrenergic receptors and muscarinic receptors. Thus, the present study suggests that MCI-9042 is specific for 5HT2-receptor.",
     "FAU": [
          "Maruyama, K",
          "Kinami, J",
          "Sugita, Y",
          "Takada, Y",
          "Sugiyama, E",
          "Tsuchihashi, H",
          "Nagatomo, T"
     ],
     "AU": [
          "Maruyama K",
          "Kinami J",
          "Sugita Y",
          "Takada Y",
          "Sugiyama E",
          "Tsuchihashi H",
          "Nagatomo T"
     ],
     "AD": "Department of Pharmacology, Niigata College of Pharmacy, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Japan",
     "TA": "J Pharmacobiodyn",
     "JT": "Journal of pharmacobio-dynamics",
     "JID": "7901854",
     "RN": [
          "0 (Adrenergic alpha-Agonists)",
          "0 (Adrenergic beta-Antagonists)",
          "0 (Platelet Aggregation Inhibitors)",
          "0 (Propanolamines)",
          "0 (Receptors, Adrenergic, alpha)",
          "0 (Receptors, Adrenergic, beta)",
          "0 (Receptors, Muscarinic)",
          "0 (Receptors, Serotonin)",
          "0 (Succinates)",
          "19P708E787 (sarpogrelate)",
          "843CEN85DI (apraclonidine)",
          "97F9DE4CT4 (Ketanserin)",
          "MN3L5RMN02 (Clonidine)",
          "R89UMZ82MJ (CGP 12177)",
          "XM03YJ541D (Prazosin)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic alpha-Agonists/pharmacology",
          "Adrenergic beta-Antagonists/pharmacology",
          "Animals",
          "Binding, Competitive",
          "Brain Chemistry/drug effects",
          "Clonidine/analogs & derivatives/pharmacology",
          "Hippocampus/drug effects/metabolism",
          "In Vitro Techniques",
          "Ketanserin/pharmacology",
          "Kinetics",
          "Platelet Aggregation Inhibitors/*pharmacology",
          "Prazosin/pharmacology",
          "Propanolamines/pharmacology",
          "Radioligand Assay",
          "Rats",
          "Receptors, Adrenergic, alpha/drug effects",
          "Receptors, Adrenergic, beta/drug effects",
          "Receptors, Muscarinic/drug effects",
          "Receptors, Serotonin/*drug effects",
          "Succinates/*pharmacology"
     ],
     "EDAT": "1991/04/01 00:00",
     "MHDA": "1991/04/01 00:01",
     "CRDT": [
          "1991/04/01 00:00"
     ],
     "PHST": [
          "1991/04/01 00:00 [pubmed]",
          "1991/04/01 00:01 [medline]",
          "1991/04/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "J Pharmacobiodyn. 1991 Apr;14(4):177-81.",
     "term": "hippocampus"
}